Surveillance for Early Liver Injuries Caused by Xianlin Gubao Capsule.

Status Not yet recruiting

Clinical Trial Summary

This is a prospective registry study to surveil early liver injuries caused by Xianlin Gubao Capsule (XLGB Capsule) through a non-intervention observational way. And attempt to establish a predictive model to screen susceptibilities to XLGB Capsule.

Clinical Trial Description

The primary objectives of this study include:

(i) The detection of patients with serum liver biochemistry abnormalities within 8 weeks after intake of XLGB Capsule; (ii) The record of overall individuals with demographics, underlying diseases, physical status, medication information, clinical laboratory index, and so on; (iii) The specimen collection of surveiled individuals. (iv) The attempt to establish a predictive model to screen susceptibilities to XLGB Capsule. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03091244
Study type	Observational [Patient Registry]
Source	Beijing 302 Hospital
Contact	Xiao-he Xiao
Phone	+86 66933322
Email	pharmacy302xxh@126.com
Status	Not yet recruiting
Phase	N/A
Start date	March 25, 2017
Completion date	December 31, 2017

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05517668` - Evaluation of the Efficacy of Fomepizole in the Treatment of Acetaminophen Overdose	Phase 2
Recruiting	`NCT05060289` - A Prognostic Model for Drug-induced Liver Injury in China
Completed	`NCT03092817` - Adjunctive Corticosteroids for Tuberculous Meningitis in HIV-infected Adults (The ACT HIV Trial)	Phase 3
Completed	`NCT03211208` - Assessing Antibiotic Induced Liver Injury for Stratification of Tuberculosis Patients
Not yet recruiting	`NCT02061826` - Establishment of Drug-induced Liver Injury Databases and Application of Circulating microRNA(miRNA)	N/A
Completed	`NCT02182167` - A Trial Of Intravenous N-Acetylcysteine In The Management Of Antituberculous Drug-Induced Hepatitis	Phase 2/Phase 3
Completed	`NCT03665402` - A Pharamcogenomic Study for Isoniazid According to NAT2 Polymorphism Status	N/A
Not yet recruiting	`NCT03091608` - Surveillance for Early Liver Injuries Caused by Xianlin Gubao Granule	N/A
Not yet recruiting	`NCT03060252` - Surveillance for Early Liver Injuries Caused by Zhuanggu Guanjie Pill	N/A
Not yet recruiting	`NCT03091218` - Surveillance for Early Liver Injuries Caused by Runzao Zhiyang Capsule.	N/A
Not yet recruiting	`NCT03091556` - Surveillance for Early Liver Injuries Caused by Xianlin Gubao Pill.	N/A
Completed	`NCT02407964` - A Retrospective Study on Drug Induced Liver Injury in China	N/A
Active, not recruiting	`NCT05144217` - Impact of Silymarin Dosages to Decrease Drug-induced Elevated Liver Enzymes Compared to Placebo	Phase 2/Phase 3
Completed	`NCT01705041` - Preliminary Evaluation of a Point-Of-Care Liver Function Test	N/A
Recruiting	`NCT02086708` - Ultrasound Method to Measure Fibrosis of the Liver in Children	N/A
Recruiting	`NCT05465642` - Alterations of Gut Microbiota and Serum Biochemical Markers in DILI Patients
Completed	`NCT01434173` - Risk of Acute Liver Injury in Users of Antimicrobials	N/A
Completed	`NCT05532345` - Discrimination of DILI and AIH by Artificial Intelligence
Completed	`NCT03602703` - Immune Responses in Hepatocellular Carcinoma Patients After Treatment With Direct Acting Antiviral Drugs
Active, not recruiting	`NCT03100786` - Leukotriene A4 Hydrolase Stratified Trial of Adjunctive Corticosteroids for HIV-uninfected Adults With Tuberculous Meningitis	Phase 3